Digital Therapeutics Market
Market Insights on Digital Therapeutics covering sales outlook, demand forecast & up-to-date key trends
Digital Therapeutics Market by Solution, Application, Indication, Business Model & Region - Forecast 2022 – 2032
Digital Therapeutics Market Outlook (2022-2032)
[300 Pages Report] The global digital therapeutics market is set to reach a valuation of US$ 4.8 Bn in 2022. Expanding at an impressive 24.4% CAGR over the forecast period, total sales in the digital therapeutics market will reach US$ 42.5 Bn by 2032.
|
Data Points |
Market Insights |
|
Digital Therapeutics Market Value (2021) |
US$ 3.9 Bn |
|
Estimated Market Value (2022) |
US$ 4.8 Bn |
|
Projected Market Size (2032) |
US$ 42.5 Bn |
|
Value-based CAGR (2022-2032) |
24.4% |
|
Market Share of Top 5 Countries |
44.4% |
Digital therapies are software solutions used in the treatment of medical disorders, and they are a new trend emerging from the rapidly progressing mobile health market. These products are similar to consumer wellness applications in which they allow consumers to have more control over their care, but with one major difference: digital therapies are focused on providing enhanced clinical outcomes.
Digital treatments can provide aid to patients at many stages of their health care journey, in addition to addressing specific medical disorders. Through the process, digital treatment (DTx) gather, synthesizes, and analyse patient data so clinical professionals can fabricate treatment options and work with the patient to wean off complications. Better outcomes and fewer medical interventions are the end results.
Let us know your requirement to get
100% FREE customization
2017-2021 Digital Therapeutics Market Historic Outlook Vs Forecast for 2022-2032
The digital therapeutics market grew at a CAGR of 22.0% between 2017 and 2021. The market value for global digital therapeutics held nearly 2.7% of the overall US$ 146 Bn digital health market in 2021.
The power of mobile technology to capture and hold people's attention is well known. A rising number of start-ups and established technology players are betting on that power to help people enhance their health outcomes in measurable ways.
These companies are driving software and health-care convergence in ways that can potentially change how the conventional approach of the life sciences industry, which involves both large pharma companies and medical technology or medical device companies, supports the patient health-care journey from beginning to end, spawning a new branch of medicine known as digital therapeutics.
Conventional therapies and treatments are still unable to meet unmet patient demand, while digital medicines offer the potential to do so. Enterprises that use digital therapies to close these gaps, together with substantially shorter product development timetables, may have a considerable edge over traditional life sciences companies.
Rising prevalence of preventable chronic diseases, the pressing need to regulate the cost of health care, a need for safe and accessible workarounds for the treatment of chronic and mental health diseases, a growing focus on predictive, preventative, personalised, and participatory healthcare, increasing investments in digital therapeutics are driving growth in the digital therapeutics market.
Digital therapeutics provide patient-oriented solutions through aspects such as digital behavioural interventions to devise evidence-based solutions on patient data, artificial intelligence and machine learning interventions, mobile health applications, gamification, and virtual reality. Driven by this, the market is expected to grow at a 24.4% CAGR and offer an absolute $ opportunity of nearly US$ 1 Bn between 2023 and 2022.
What are the Key Opportunities Propelling the Demand for Digital Therapeutics?
Numerous start-ups and existing technology companies are banking on the ability of mobile technology to help people improve their health in quantifiable ways. Manufacturers are driving software and healthcare convergence in ways that are expected to change the life sciences industry's traditional approach, which includes both large pharma and medical technology or medical device companies, supports the patient's medical journey. This has spawned a new branch of medicine known as digital therapeutics and will provide lucrative opportunities for growth over the forecast period.
Furthermore, digital therapeutics provide pharmaceutical and MedTech businesses with a low-cost approach to differentiate products, especially when compared to the research and development costs generally involved with traditional medicine or medical device.
Many businesses are refocusing their R&D efforts away from core product lines and toward revolutionary innovation. Digital medicines also have the potential to lengthen product life cycles, differentiate in-development goods, and cover market gaps that traditional medicine may not be able to fill. All these factors are expected to augment the growth in the market over the assessment period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Factors are Limiting Sales in the Digital Therapeutics Market?
Wearable healthcare faces several challenges, including the fact that the data provided cannot always be used to track, diagnose, and treat health disorders due to ongoing concerns about data accuracy, consistency, and privacy.
Additionally, stakeholder awareness, acceptance, and engagement are issues for many firms that have joined the DTx industry. Most DTx solutions have entered the market with product-centric revenue models and go-to-market strategies to date.
Instead of satisfying unmet requirements of patients and other essential stakeholders across the end-to-end continuum of care, their focus has been on selling more products. As a result, the market for isolated digital point solutions is fragmented, confused, and overcrowded. There is no genuinely comprehensive, patient-centric experience to assist patients in navigating the present complex healthcare system.
As a result of the additional time and money spent on product development, the marketing and commercial sales teams are underp ressure to produce successful go-to-market plans for DTx launch, scale-up, and growth. These factors, together, induce a restrictive impact upon the growth of the overall digital therapeutics market.
Country-wise Insights
What Makes the U.S. the Largest Market for Digital Therapeutics?
“Rapid Adoption of Connective Technology-Based Medical Equipment Will Fuel Sales of Digital Therapeutics”
The U.S. dominated the North America digital therapeutics market in 2021, holding about 90.3% of the market share. As per FMI, the trend is projected to continue over the forecast period. Growth is associated with the high burden of chronic disease in the general population within the country.
Increasing incidence of gastrointestinal and central nervous system diseases is underpinning the demand for digital therapeutics. With growing adoption of telemedicine, integration and adoption of mobile health analytics in the U.S., sales are expected to increase over the forecast period.
Why is China Considered a Lucrative Market for Digital Therapeutics?
“Growing Demand for Digital Therapeutics for Insomnia Will Augment Growth”
China is expected to account for 48.0% of the East Asia digital therapeutics market share in 2022. After the third wave of automation and digital technology integration propelled by the advent of the COVID-19 pandemic, China has established full automation solutions for medical and production facilities.
The local government has joined forces with leading DTx organisations with a joint commitment of 20 billion RMB ($32 billion) in funding support to formalise a massive DTx Industrial Park project, which is a promising indicator of Chinese DTx market progress. The project's details and funding proposal have yet to be revealed, but a newly built DTx Industrial Park in Zhejiang Province will soon serve as the DTx industrial flagship in China.
What is Driving the Germany Digital Therapeutics Market?
“Rising Awareness Regarding Digital Therapeutics Technology Will Boost Sales in Germany”
With a high volume of the disease burden associated with chronic ailments such as cardiovascular diseases, diabetes, and cancer, demand for digital therapeutics in Germany is anticipated to remain high. As per the report, the Germany digital therapeutics market will expand at a 20.6% CAGR over the forecast period.
In 2019, the German Parliament passed the Digital Healthcare Act (DigitaleVersorgung-Gesetz, or DVG), allowing all German doctors to prescribe digital treatments to publicly-insured patients in Germany. This has enhanced the accessibility of safe digital solutions for the treatment of chronic and mental health diseases.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Which Digital Therapeutics Solution is Widely Adopted?
“Demand for Combination Therapy Will Gain Traction”
Based on solution, the combination therapy segment is projected to account for 68.4% of the total market share in 2022. Combination therapy with biopharmaceuticals, or “smart drugs” offers an exciting way to improve patient adherence and outcomes. Pharmaceutical companies can assist patients in improving their health outcomes by digitising drugs and utilising digital interventions to encourage their proper usage.
Which Applications of Digital Therapeutics are Driving the Market?
“Adoption of Digital Therapeutics for Disease Prevention Will Rise”
In terms of applications, the prevention segment is forecast to hold 35.8% of the total market share in 2022. For patients at risk of developing more serious ailments, digital therapeutics are routinely used as a prophylactic measure. These prevention measures provide approaches and solutions that could delay the onset of the chronic disease.
Which Indication is More in Focus in the Digital Therapeutics Market?
“Sales of Digital Therapeutics for Central Nervous Systems Disorders Will Boost Demand”
By indication, sales in the central nervous system disorders segment will increase at a CAGR of 29.2% over the assessment period. Several drugs that are now in use were discovered as a result of drug discovery research intended to treat central nervous system (CNS) illnesses.
However, not all drugs can relieve patients of the symptoms of their disorders, and CNS dysfunction is still a medical area with many unmet needs. Medical solutions which utilize digital technologies can address these unmet needs.
Which Business Model is Most Preferred For Digital Therapeutics?
“Sales of Digital Therapeutics Direct to Patients Will Gain Momentum”
Based on distribution channel, the direct-to-patients/consumers segment will hold about 60.1% of the total market share over the forecast period. With the products being sold directly to the consumer, the availability of mobile health solutions provide customers with solutions linked to enhanced patient compliance and better clinical outcomes.
Competitive Landscape
The market for digital therapeutics is a fragmented. With the emergence of start-ups and other market players, the global market is likely to witness the heavy competition. Companies are aiming to launch digital health campaigns and software solutions for a comprehensive patient care regimen. For instance:
- Teladoc Health in February 2022 launched the “Chronic Care Complete” management solution aimed at improving health outcomes for patients living with chronic conditions.
- • In September 2020, Boehringer Ingelheim and Click Therapeutics agreed to collaborate on the development and commercialization of CT-155, a novel prescription digital therapy for schizophrenia.
Report Scope as per Digital Therapeutics Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2017-2021 |
|
Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
|
Key Countries Covered
|
The U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, Spain, the U.K., Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC Countries and Turkey |
|
Key Companies Covered |
|
|
Key Market Segments Covered |
Solution, Application, Indication, Business Model and Region |
Key Market Segments Covered in Digital Therapeutics Industry Research
By Solution:
- Monotherapy
- Combination Therapy
By Application:
- Prevention
- Management
- Treatment
By Indication:
- Diabetes
- Obesity
- Gastrointestinal Disorders
- Cardiovascular Disease
- Central Nervous Systems
- Others
By Business Model:
- Direct to consumer
- Fee-for-service
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa (MEA)
Frequently Asked Questions
The global digital therapeutics market is worth US$ 4.8 Bn in 2022 and is set to expand 8.9X over the next ten years.
The global digital therapeutics market is expected to reach US$ 42.5 Bn by the end of 2032, with sales revenue expected to register a 24.4% CAGR.
Some of the significant trends in this market are the reimagined regulatory pathway for software as a medical device (SaMD) products, the rising adoption of medical technology, and the global prevalence of chronic and mental diseases.
Canada, the U.S., France, the U.K., and Italy are expected to drive demand for global digital therapeutics products.
The U.S. is one of the key markets for global digital therapeutics, accounting for about 86.2% of the overall North American market during the forecast period.
The U.S., Germany and Canada are the key producers in the global digital therapeutics market space.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Key Strategies, By Key Players
4.2. Regulatory Landscape
4.3. Reimbursement Scenario
4.4. Collaboration between pharma & digital therapeutics providers
4.5. PESTEL Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Digital Health Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising prevalence of chronic diseases
5.2.2. Technological Advancements
5.2.3. Rising adoption of telehealth
5.2.4. Cost-effectiveness
5.2.5. Supportive rules and regulations
5.2.6. Rise in demand for digital therapeutics
5.2.7. Strategic Mergers and Acquisitions
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. COVID19 and Impact Analysis
6.1.1. By Solution
6.1.2. By Application
6.1.3. By Indication
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Digital Therapeutics Market Demand (in Value or Size in US$ Bn) Analysis 2017-2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Solution
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Solution, 2017-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2022–2032
8.3.1. Monotherapy
8.3.2. Combination Therapy
8.4. Market Attractiveness Analysis By Solution
9. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2017-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022–2032
9.3.1. Prevention
9.3.2. Management
9.3.3. Treatment
9.4. Market Attractiveness Analysis By Application
10. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2017-2021
10.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Indication, 2022–2032
10.3.1. Diabetes
10.3.2. Obesity
10.3.3. Gastrointestinal Disorders
10.3.4. Cardiovascular Disease
10.3.5. Central Nervous Systems
10.3.6. Others
10.4. Market Attractiveness Analysis By Indication
11. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Business Model
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By Business Model, 2017-2021
11.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Business Model, 2022–2032
11.3.1. Direct to consumer
11.3.2. Fee-for-service
11.4. Market Attractiveness Analysis By Business Model
12. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2017-2021
12.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
13.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Solution
13.3.3. By Application
13.3.4. By Indication
13.3.5. By Business Model
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Solution
13.4.3. By Application
13.4.4. By Indication
13.4.5. By Business Model
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Digital Therapeutics Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Solution
13.8.1.2.2. By Application
13.8.1.2.3. By Indication
13.8.1.2.4. By Business Model
13.8.2. Canada Digital Therapeutics Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Solution
13.8.2.2.2. By Application
13.8.2.2.3. By Indication
13.8.2.2.4. By Business Model
14. Latin America Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
14.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Solution
14.3.3. By Application
14.3.4. By Indication
14.3.5. By Business Model
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Solution
14.4.3. By Application
14.4.4. By Indication
14.4.5. By Business Model
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Digital Therapeutics Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Solution
14.8.1.2.2. By Application
14.8.1.2.3. By Indication
14.8.1.2.4. By Business Model
14.8.2. Brazil Digital Therapeutics Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Solution
14.8.2.2.2. By Application
14.8.2.2.3. By Indication
14.8.2.2.4. By Business Model
14.8.3. Argentina Digital Therapeutics Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Solution
14.8.3.2.2. By Application
14.8.3.2.3. By Indication
14.8.3.2.4. By Business Model
15. Europe Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
15.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Nordic Countries & Russia
15.3.1.8. Rest of Europe
15.3.2. By Solution
15.3.3. By Application
15.3.4. By Indication
15.3.5. By Business Model
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Solution
15.4.3. By Application
15.4.4. By Indication
15.4.5. By Business Model
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Digital Therapeutics Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Solution
15.8.1.2.2. By Application
15.8.1.2.3. By Indication
15.8.1.2.4. By Business Model
15.8.2. Italy Digital Therapeutics Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. B By Solution
15.8.2.2.2. By Application
15.8.2.2.3. By Indication
15.8.2.2.4. By Business Model
15.8.3. France Digital Therapeutics Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Solution
15.8.3.2.2. By Application
15.8.3.2.3. By Indication
15.8.3.2.4. By Business Model
15.8.4. U.K. Digital Therapeutics Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Solution
15.8.4.2.2. By Application
15.8.4.2.3. By Indication
15.8.4.2.4. By Business Model
15.8.5. Spain Digital Therapeutics Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Solution
15.8.5.2.2. By Application
15.8.5.2.3. By Indication
15.8.5.2.4. By Business Model
15.8.6. BENELUX Digital Therapeutics Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Solution
15.8.6.2.2. By Application
15.8.6.2.3. By Indication
15.8.6.2.4. By Business Model
15.8.7. Nordic Countries & Russia Digital Therapeutics Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Solution
15.8.7.2.2. By Application
15.8.7.2.3. By Indication
15.8.7.2.4. By Business Model
16. East Asia Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
16.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Solution
16.3.3. By Application
16.3.4. By Indication
16.3.5. By Business Model
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Solution
16.4.3. By Application
16.4.4. By Indication
16.4.5. By Business Model
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Digital Therapeutics Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Solution
16.8.1.2.2. By Application
16.8.1.2.3. By Indication
16.8.1.2.4. By Business Model
16.8.2. Japan Digital Therapeutics Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Solution
16.8.2.2.2. By Application
16.8.2.2.3. By Indication
16.8.2.2.4. By Business Model
16.8.3. South Korea Digital Therapeutics Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Solution
16.8.3.2.2. By Application
16.8.3.2.3. By Indication
16.8.3.2.4. By Business Model
17. South Asia Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
17.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Philippines
17.3.1.6. Vietnam
17.3.1.7. Rest of South Asia
17.3.2. By Solution
17.3.3. By Application
17.3.4. By Indication
17.3.5. By Business Model
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Solution
17.4.3. By Application
17.4.4. By Indication
17.4.5. By Business Model
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Digital Therapeutics Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Solution
17.8.1.2.2. By Application
17.8.1.2.3. By Indication
17.8.1.2.4. By Business Model
17.8.2. Indonesia Digital Therapeutics Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Solution
17.8.2.2.2. By Application
17.8.2.2.3. By Indication
17.8.2.2.4. By Business Model
17.8.3. Malaysia Digital Therapeutics Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Solution
17.8.3.2.2. By Application
17.8.3.2.3. By Indication
17.8.3.2.4. By Business Model
17.8.4. Thailand Digital Therapeutics Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Solution
17.8.4.2.2. By Application
17.8.4.2.3. By Indication
17.8.4.2.4. By Business Model
17.8.5. Philippines Digital Therapeutics Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Solution
17.8.5.2.2. By Application
17.8.5.2.3. By Indication
17.8.5.2.4. By Business Model
17.8.6. Vietnam Digital Therapeutics Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Solution
17.8.6.2.2. By Application
17.8.6.2.3. By Indication
17.8.6.2.4. By Business Model
18. Oceania Digital Therapeutics Market 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
18.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Solution
18.3.3. By Application
18.3.4. By Indication
18.3.5. By Business Model
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Solution
18.4.3. By Application
18.4.4. By Indication
18.4.5. By Business Model
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Australia Digital Therapeutics Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Solution
18.7.1.2.2. By Application
18.7.1.2.3. By Indication
18.7.1.2.4. By Business Model
18.7.2. New Zealand Digital Therapeutics Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Solution
18.7.2.2.2. By Application
18.7.2.2.3. By Indication
18.7.2.2.4. By Business Model
19. Middle East and Africa (MEA) Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021
19.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Israel
19.3.1.3. Turkey
19.3.1.4. South Africa & North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Solution
19.3.3. By Application
19.3.4. By Indication
19.3.5. By Business Model
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Solution
19.4.3. By Application
19.4.4. By Indication
19.4.5. By Business Model
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Digital Therapeutics Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Solution
19.8.1.2.2. By Application
19.8.1.2.3. By Indication
19.8.1.2.4. By Business Model
19.8.2. Israel Digital Therapeutics Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Solution
19.8.2.2.2. By Application
19.8.2.2.3. By Indication
19.8.2.2.4. By Business Model
19.8.3. Turkey Digital Therapeutics Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Solution
19.8.3.2.2. By Application
19.8.3.2.3. By Indication
19.8.3.2.4. By Business Model
19.8.4. South Africa & North Africa Digital Therapeutics Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Solution
19.8.4.2.2. By Application
19.8.4.2.3. By Indication
19.8.4.2.4. By Business Model
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. By Regional Footprint of Players
20.3.2. By Channel Footprint of Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Teladoc Health, Inc.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. Sales Footprint
21.3.1.5. SWOT Analysis
21.3.1.6. Strategy Overview
21.3.1.6.1. Marketing Strategy
21.3.1.6.2. Channel Strategy
21.3.2. Click Therapeutics, Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. Sales Footprint
21.3.2.5. SWOT Analysis
21.3.2.6. Strategy Overview
21.3.2.6.1. Marketing Strategy
21.3.2.6.2. Channel Strategy
21.3.3. Welldoc
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. Sales Footprint
21.3.3.5. SWOT Analysis
21.3.3.6. Strategy Overview
21.3.3.6.1. Marketing Strategy
21.3.3.6.2. Channel Strategy
21.3.4. HYGIEIA
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. Sales Footprint
21.3.4.5. SWOT Analysis
21.3.4.6. Strategy Overview
21.3.4.6.1. Marketing Strategy
21.3.4.6.2. Channel Strategy
21.3.5. DarioHealth Corp
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. Sales Footprint
21.3.5.5. SWOT Analysis
21.3.5.6. Strategy Overview
21.3.5.6.1. Marketing Strategy
21.3.5.6.2. Channel Strategy
21.3.6. BigHealth
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. Sales Footprint
21.3.6.5. SWOT Analysis
21.3.6.6. Strategy Overview
21.3.6.6.1. Marketing Strategy
21.3.6.6.2. Channel Strategy
21.3.7. Orexo AB
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. Sales Footprint
21.3.7.5. SWOT Analysis
21.3.7.6. Strategy Overview
21.3.7.6.1. Marketing Strategy
21.3.7.6.2. Channel Strategy
21.3.8. Akili Interactive Labs, Inc.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. Sales Footprint
21.3.8.5. SWOT Analysis
21.3.8.6. Strategy Overview
21.3.8.6.1. Marketing Strategy
21.3.8.6.2. Channel Strategy
21.3.9. Freespira
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. Sales Footprint
21.3.9.5. SWOT Analysis
21.3.9.6. Strategy Overview
21.3.9.6.1. Marketing Strategy
21.3.9.6.2. Channel Strategy
21.3.10. Voluntis
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. Sales Footprint
21.3.10.5. SWOT Analysis
21.3.10.6. Strategy Overview
21.3.10.6.1. Marketing Strategy
21.3.10.6.2. Channel Strategy
21.3.11. Kaia Health
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Key Financials
21.3.11.4. Sales Footprint
21.3.11.5. SWOT Analysis
21.3.11.6. Strategy Overview
21.3.11.6.1. Marketing Strategy
21.3.11.6.2. Channel Strategy
21.3.12. Kaiku Health
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Key Financials
21.3.12.4. Sales Footprint
21.3.12.5. SWOT Analysis
21.3.12.6. Strategy Overview
21.3.12.6.1. Marketing Strategy
21.3.12.6.2. Channel Strategy
21.3.13. Theranica Bio-Electronics Ltd.
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Key Financials
21.3.13.4. Sales Footprint
21.3.13.5. SWOT Analysis
21.3.13.6. Strategy Overview
21.3.13.6.1. Marketing Strategy
21.3.13.6.2. Channel Strategy
21.3.14. Propeller Health
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Key Financials
21.3.14.4. Sales Footprint
21.3.14.5. SWOT Analysis
21.3.14.6. Strategy Overview
21.3.14.6.1. Marketing Strategy
21.3.14.6.2. Channel Strategy
21.3.15. Orexo US, Inc.
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Key Financials
21.3.15.4. Sales Footprint
21.3.15.5. SWOT Analysis
21.3.15.6. Strategy Overview
21.3.15.6.1. Marketing Strategy
21.3.15.6.2. Channel Strategy
21.3.16. TALi Digital Limited
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Key Financials
21.3.16.4. Sales Footprint
21.3.16.5. SWOT Analysis
21.3.16.6. Strategy Overview
21.3.16.6.1. Marketing Strategy
21.3.16.6.2. Channel Strategy
21.3.17. Limbix Health, Inc.
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Key Financials
21.3.17.4. Sales Footprint
21.3.17.5. SWOT Analysis
21.3.17.6. Strategy Overview
21.3.17.6.1. Marketing Strategy
21.3.17.6.2. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032
Table 02: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 03: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Application
Table 04: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Indication
Table 05: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Business Model
Table 06: Global Digital Therapeutics Market Application (US$ Bn) Analysis 2017–2021 and Forecast 2022-2032, by Region
Table 07: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 08: North America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 09: North America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 10: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 11: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 12: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 13: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 14: Latin America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 15: Latin America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 16: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 17: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 18: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 19: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 20: Europe Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 21: Europe Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 22: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 23: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 24: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 25: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 26: South Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 27: South Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 28: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 29: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 30: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 31: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 32: East Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 33: East Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 34: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 35: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 36: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 37: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 38: Oceania Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 39: Oceania Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 40: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 41: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 42: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Table 43: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country
Table 44: MEA Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 45: MEA Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution
Table 46: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application
Table 47: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication
Table 48: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Digital Therapeutics Market Value Share, by Solution 2022(E)
Figure 02: Global Digital Therapeutics Market Value Share, by Application 2022(E)
Figure 03: Global Digital Therapeutics Market Value Share, by Indication 2022(E)
Figure 04: Global Digital Therapeutics Market Value Share, by Business Model 2022(E)
Figure 05: Global Digital Therapeutics Market Value (US$ Mn) Analysis, 2017–2021
Figure 06: Global Digital Therapeutics Market Value (US$ Mn) Forecast, 2021–2032
Figure 07: Global Digital Therapeutics Market Absolute $ Opportunity, 2022 - 2032
Figure 08: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Solution
Figure 09: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Solution
Figure 10: Global Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 11: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Application
Figure 12: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Application
Figure 13: Global Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 14: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Indication
Figure 15: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Indication
Figure 16: Global Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 17: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Business Model
Figure 18: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Business Model
Figure 19: Global Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 20: Global Digital Therapeutics Market Share, by Region, 2022 & 2032
Figure 21: Global Digital Therapeutics Market Attractiveness Analysis by Region, 2022-2032
Figure 22: Global Digital Therapeutics Market Attractiveness Analysis by Region, 2021-2031
Figure 23: North America Digital Therapeutics Market Share, by Country (2022)
Figure 24: North America Digital Therapeutics Market Share, by Solution (2022)
Figure 25: North America Digital Therapeutics Market Share, by Application (2022)
Figure 26: North America Digital Therapeutics Market Share, by Indication (2022)
Figure 27: North America Digital Therapeutics Market Share, by Business Model (2022)
Figure 28: North America Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 29: North America Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 30: North America Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 31: North America Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 32: North America Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 33: North America Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 34: North America Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 35: Latin America Digital Therapeutics Market Share, by Country (2022)
Figure 36: Latin America Digital Therapeutics Market Share, by Solution (2022)
Figure 37: Latin America Digital Therapeutics Market Share, by Application (2022)
Figure 38: Latin America Digital Therapeutics Market Share, by Indication (2022)
Figure 39: Latin America Digital Therapeutics Market Share, by Business Model (2022)
Figure 40: Latin America Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 41: Latin America Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 42: Latin America Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 43: Latin America Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 44: Latin America Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 45: Latin America Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 46: Latin America Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 47: Europe Digital Therapeutics Market Share, by Country (2022)
Figure 48: Europe Digital Therapeutics Market Share, by Solution (2022)
Figure 49: Europe Digital Therapeutics Market Share, by Application (2022)
Figure 50: Europe Digital Therapeutics Market Share, by Indication (2022)
Figure 51: Europe Digital Therapeutics Market Share, by Business Model (2022)
Figure 52: Europe Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 53: Europe Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 54: Europe Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 55: Europe Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 56: Europe Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 57: Europe Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 58: Europe Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 59: South Asia Digital Therapeutics Market Share, by Country (2022)
Figure 60: South Asia Digital Therapeutics Market Share, by Solution (2022)
Figure 61: South Asia Digital Therapeutics Market Share, by Application (2022)
Figure 62: South Asia Digital Therapeutics Market Share, by Indication (2022)
Figure 63: South Asia Digital Therapeutics Market Share, by Business Model (2022)
Figure 64: South Asia Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 65: South Asia Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 66: South Asia Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 67: South Asia Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 68: South Asia Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 69: South Asia Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 70: South Asia Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 71: East Asia Digital Therapeutics Market Share, by Country (2022)
Figure 72: East Asia Digital Therapeutics Market Share, by Solution (2022)
Figure 73: East Asia Digital Therapeutics Market Share, by Application (2022)
Figure 74: East Asia Digital Therapeutics Market Share, by Indication (2022)
Figure 75: East Asia Digital Therapeutics Market Share, by Business Model (2022)
Figure 76: East Asia Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 77: East Asia Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 78: East Asia Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 79: East Asia Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 80: East Asia Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 81: East Asia Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 82: East Asia Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 83: Oceania Digital Therapeutics Market Share, by Country (2022)
Figure 84: Oceania Digital Therapeutics Market Share, by Solution (2022)
Figure 85: Oceania Digital Therapeutics Market Share, by Application (2022)
Figure 86: Oceania Digital Therapeutics Market Share, by Indication (2022)
Figure 87: Oceania Digital Therapeutics Market Share, by Business Model (2022)
Figure 88: Oceania Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 89: Oceania Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 90: Oceania Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 91: Oceania Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 92: Oceania Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 93: Oceania Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 94: Oceania Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 95: MEA Digital Therapeutics Market Share, by Country (2022)
Figure 96: MEA Digital Therapeutics Market Share, by Solution (2022)
Figure 97: MEA Digital Therapeutics Market Share, by Application (2022)
Figure 98: MEA Digital Therapeutics Market Share, by Indication (2022)
Figure 99: MEA Digital Therapeutics Market Share, by Business Model (2022)
Figure 100: MEA Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021
Figure 101: MEA Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032
Figure 102: MEA Digital Therapeutics Market Attractiveness Analysis, by Country
Figure 103: MEA Digital Therapeutics Market Attractiveness Analysis, by Solution
Figure 104: MEA Digital Therapeutics Market Attractiveness Analysis, by Application
Figure 105: MEA Digital Therapeutics Market Attractiveness Analysis, by Indication
Figure 106: MEA Digital Therapeutics Market Attractiveness Analysis, by Business Model
Figure 107: Global Digital Therapeutics Market Value Proportion Analysis, by Countries, 2022
Figure 108: Global Digital Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032
Figure 109: U.S. Market Value Proportion Analysis, 2022
Figure 110: Global Vs. U.S. Growth Comparison
Figure 111: U.S. Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 112: U.S. Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 113: U.S. Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 114: U.S. Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 115: Canada Market Value Proportion Analysis, 2022
Figure 116: Global Vs. Canada Growth Comparison
Figure 117: Canada Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 118: Canada Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 119: Canada Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 120: Canada Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 121: Brazil Market Value Proportion Analysis, 2022
Figure 122: Global Vs. Brazil Growth Comparison
Figure 123: Brazil Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 124: Brazil Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 125: Brazil Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 126: Brazil Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 127: Mexico Market Value Proportion Analysis, 2022
Figure 128: Global Vs. Mexico Growth Comparison
Figure 129: Mexico Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 130: Mexico Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 131: Mexico Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 132: Mexico Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 133: Germany Market Value Proportion Analysis, 2022
Figure 134: Global Vs. Germany Growth Comparison
Figure 135: Germany Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 136: Germany Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 137: Germany Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 138: Germany Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 139: Italy Market Value Proportion Analysis, 2022
Figure 140: Global Vs. Italy Growth Comparison
Figure 141: Italy Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 142: Italy Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 143: Italy Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 144: Italy Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 145: France Market Value Proportion Analysis, 2022
Figure 146: Global Vs. France Growth Comparison
Figure 147: France Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 148: France Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 149: France Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 150: France Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 151: U.K Market Value Proportion Analysis, 2022
Figure 152: Global Vs. U.K Growth Comparison
Figure 153: U.K Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 154: U.K Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 155: U.K Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 156: U.K Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 157: Spain Market Value Proportion Analysis, 2022
Figure 158: Global Vs. Spain Growth Comparison
Figure 159: Spain Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 160: Spain Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 161: Spain Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 162: Spain Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 163: BENELUX Market Value Proportion Analysis, 2022
Figure 164: Global Vs. BENELUX Growth Comparison
Figure 165: BENELUX Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 166: BENELUX Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 167: BENELUX Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 168: BENELUX Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 169: Russia Market Value Proportion Analysis, 2022
Figure 170: Global Vs. Russia Growth Comparison
Figure 171: Russia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 172: Russia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 173: Russia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 174: Russia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 175: India Market Value Proportion Analysis, 2022
Figure 176: Global Vs. India Growth Comparison
Figure 177: India Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 178: India Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 179: India Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 180: India Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 181: Thailand Market Value Proportion Analysis, 2022
Figure 182: Global Vs. Thailand Growth Comparison
Figure 183: Thailand Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 184: Thailand Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 185: Thailand Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 186: Thailand Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 187: Malaysia Market Value Proportion Analysis, 2022
Figure 188: Global Vs. Malaysia Growth Comparison
Figure 189: Malaysia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 190: Malaysia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 191: Malaysia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 192: Malaysia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 193: Indonesia Market Value Proportion Analysis, 2022
Figure 194: Global Vs. Indonesia Growth Comparison
Figure 195: Indonesia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 196: Indonesia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 197: Indonesia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 198: Indonesia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 199: China Market Value Proportion Analysis, 2022
Figure 200: Global Vs. China Growth Comparison
Figure 201: China Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 202: China Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 203: China Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 204: China Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 205: Japan Market Value Proportion Analysis, 2022
Figure 206: Global Vs. Japan Growth Comparison
Figure 207: Japan Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 208: Japan Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 209: Japan Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 210: Japan Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 211: South Korea Market Value Proportion Analysis, 2022
Figure 212: Global Vs. South Korea Growth Comparison
Figure 213: South Korea Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 214: South Korea Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 215: South Korea Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 216: South Korea Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 217: Australia Market Value Proportion Analysis, 2022
Figure 218: Global Vs. Australia Growth Comparison
Figure 219: Australia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 220: Australia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 221: Australia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 222: Australia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 223: New Zealand Market Value Proportion Analysis, 2022
Figure 224: Global Vs. New Zealand Growth Comparison
Figure 225: New Zealand Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 226: New Zealand Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 227: New Zealand Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 228: New Zealand Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 229: GCC Countries Market Value Proportion Analysis, 2022
Figure 230: Global Vs. GCC Countries Growth Comparison
Figure 231: GCC Countries Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 232: GCC Countries Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 233: GCC Countries Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 234: GCC Countries Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 235: Turkey Market Value Proportion Analysis, 2022
Figure 236: Global Vs. Turkey Growth Comparison
Figure 237: Turkey Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 238: Turkey Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 239: Turkey Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 240: Turkey Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 241: Israel Market Value Proportion Analysis, 2022
Figure 242: Global Vs. Israel Growth Comparison
Figure 243: Israel Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 244: Israel Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 245: Israel Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 246: Israel Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Figure 247: South Africa Market Value Proportion Analysis, 2022
Figure 248: Global Vs. South Africa Growth Comparison
Figure 249: South Africa Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032
Figure 250: South Africa Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032
Figure 251: South Africa Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032
Figure 252: South Africa Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
